A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide
Clinical trial NCT05414123 · TERMINATED
Trial details
- NCT number
- NCT05414123
- Sponsor
- Biocept, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-07
- Primary completion
- 2023-10-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.